There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.
Effective analytics will eliminate failures, deviations, and non-conformances.
ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs, which the group is particularly concerned about.
ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San Francisco appoints VP of process science; more...
ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech; Sigma-Aldrich appoints VP and board member; more...
AAPS President offers hope and solutions for the industry's challenging future.
Is the square root of (N) + 1 a statistically valid scheme?
Industry, equipment vendors, and regulators are busy refining the precision and reliability of dissolution testing.
Using handheld Raman spectroscopy, methods were developed and evaluated for 198 substances widely used as raw materials.
The nation's healtcare system needs an overhaul, but it has to be done right.
Brief pharmaceutical news items for October 2009.
The author discusses control strategies via near infrared instrumentation for continuous mixing, granulation, drying, and extrusion with a more focused detail on mixing.
USP workshop participants support new methods to safeguard heparin products but desire international harmonization. This article contains bonus online-exclusive material.
A review of NIPTE's core projects and its plans for training-and retraining-the pharmaceutical industry.
Pharmaceutical Technology Europe PTE
Dr Martin Cockcroft, Operations Manager at Tepnel Pharmaceutical Services, an established business of Gen-Probe Inc., speaks about harmonized microbiology methods.
ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam Molecular Therapeutics appoints CEO; more...
ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO; more...
ePT--the Electronic Newsletter of Pharmaceutical Technology
The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5, 2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active pharmaceutical ingredients (APIs).
ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn Group appoints CEO of US business; more...
ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma appoints CEO and chairman; more...
ePT--the Electronic Newsletter of Pharmaceutical Technology
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...
Brief pharmaceutical news items for September 2009.
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
As new process validation guidelines emerge, industry needs to reinvent how it releases product.
IPEC's new stability testing guide takes into account the full supply chain's storage conditions.
Pharmaceutical Technology Europe
When validating automated systems from third-party providers, using the V model and failure modes effects and criticality analysis (FMECA) early in the process can help.
ePT--the Electronic Newsletter of Pharmaceutical Technology
Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more...
